Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI114562

Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.

J A Berliner, M C Territo, A Sevanian, S Ramin, J A Kim, B Bamshad, M Esterson, and A M Fogelman

Department of Pathology, University of California, School of Medicine, Los Angeles 90024-1732.

Find articles by Berliner, J. in: PubMed | Google Scholar

Department of Pathology, University of California, School of Medicine, Los Angeles 90024-1732.

Find articles by Territo, M. in: PubMed | Google Scholar

Department of Pathology, University of California, School of Medicine, Los Angeles 90024-1732.

Find articles by Sevanian, A. in: PubMed | Google Scholar

Department of Pathology, University of California, School of Medicine, Los Angeles 90024-1732.

Find articles by Ramin, S. in: PubMed | Google Scholar

Department of Pathology, University of California, School of Medicine, Los Angeles 90024-1732.

Find articles by Kim, J. in: PubMed | Google Scholar

Department of Pathology, University of California, School of Medicine, Los Angeles 90024-1732.

Find articles by Bamshad, B. in: PubMed | Google Scholar

Department of Pathology, University of California, School of Medicine, Los Angeles 90024-1732.

Find articles by Esterson, M. in: PubMed | Google Scholar

Department of Pathology, University of California, School of Medicine, Los Angeles 90024-1732.

Find articles by Fogelman, A. in: PubMed | Google Scholar

Published April 1, 1990 - More info

Published in Volume 85, Issue 4 on April 1, 1990
J Clin Invest. 1990;85(4):1260–1266. https://doi.org/10.1172/JCI114562.
© 1990 The American Society for Clinical Investigation
Published April 1, 1990 - Version history
View PDF
Abstract

The effect of minimally modified LDL (MM-LDL) on the ability of large vessel endothelial cells (EC) to interact with monocytes and neutrophils was examined. These LDL preparations, obtained by storage or by mild iron oxidation, were indistinguishable from native LDL to the LDL receptor and were not recognized by the scavenger receptor. Treatment of EC with as little as 0.12 micrograms/ml MM-LDL caused a significant increase in the production of chemotactic factor for monocytes (sevenfold) and increased monocyte binding (three- to fivefold). Monocyte binding was maximal after 4 h of EC exposure to MM-LDL, persisted for 48 h, and was inhibited by cycloheximide. In contrast, neutrophil binding was not increased after 1-24 h of exposure. Activity in the MM-LDL preparations was found primarily in the polar lipid fraction. MM-LDL was toxic for EC from one rabbit but not toxic for the cells from another rabbit or any human umbilical vein EC. The resistant cells became sensitive when incubated with lipoprotein in the presence of cycloheximide, whereas the sensitive strain became resistant when preincubated with sublethal concentrations of MM-LDL. We conclude that exposure of EC to sublethal levels of MM-LDL enhances monocyte endothelial interactions and induces resistance to the toxic effects of MM-LDL.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1260
page 1260
icon of scanned page 1261
page 1261
icon of scanned page 1262
page 1262
icon of scanned page 1263
page 1263
icon of scanned page 1264
page 1264
icon of scanned page 1265
page 1265
icon of scanned page 1266
page 1266
Version history
  • Version 1 (April 1, 1990): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts